 | • レポートコード：B-GIR09D4310 • 出版社/出版日：GlobalInfoResearch / 2019年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、物質使用障害（SUD）治療の世界市場について調べ、まとめました。種類別セグメントは、オピオイド中毒、タバコ/ニコチン中毒、アルコール依存症等、用途別セグメントは、病院及びクリニック、住宅（病院以外）等に区分しました。物質使用障害（SUD）治療の世界市場概観、企業動向、企業別物質使用障害（SUD）治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・物質使用障害（SUD）治療の市場概観 ・物質使用障害（SUD）治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・物質使用障害（SUD）治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・物質使用障害（SUD）治療の世界市場規模 ・物質使用障害（SUD）治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・物質使用障害（SUD）治療のアメリカ市場規模推移 ・物質使用障害（SUD）治療のカナダ市場規模推移 ・物質使用障害（SUD）治療のメキシコ市場規模推移 ・物質使用障害（SUD）治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・物質使用障害（SUD）治療のドイツ市場規模推移 ・物質使用障害（SUD）治療のイギリス市場規模推移 ・物質使用障害（SUD）治療のロシア市場規模推移 ・物質使用障害（SUD）治療のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・物質使用障害（SUD）治療の日本市場規模推移 ・物質使用障害（SUD）治療の中国市場規模推移 ・物質使用障害（SUD）治療の韓国市場規模推移 ・物質使用障害（SUD）治療のインド市場規模推移 ・物質使用障害（SUD）治療の東南アジア市場規模推移 ・物質使用障害（SUD）治療の南米市場分析（ブラジル、アルゼンチン等） ・物質使用障害（SUD）治療の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・物質使用障害（SUD）治療の種類別分析/販売量、売上、市場シェア（オピオイド中毒、タバコ/ニコチン中毒、アルコール依存症） ・物質使用障害（SUD）治療の用途別分析/市場規模（病院及びクリニック、住宅（病院以外）） ・物質使用障害（SUD）治療の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・物質使用障害（SUD）治療の販売チャネル・代理店・貿易業者・ディーラー分析 |
A substance use disorder (SUD), also known as a drug use disorder, is a medical condition in which the use of one or more substances leads to a clinically significant impairment or distress. Theres is habitually, dependence of an individual on any drugs, which turns into an addiction. Opioid, alcohol, tobacco and cigarettes are some of the common, drugs which has been misused leading to drugs addictions. In recent past, many products have been launched in market for treatment and management of SUD. Some commonly used drug for treatment of SUD are Disulfiram, Acamprosate, Naltrexone, Nicotine Replacement Treatment, Methadone, and Buprenorphine.
Scope of the Report:
The global Substance Use Disorders (SUDs) Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Substance Use Disorders (SUDs) Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Substance Use Disorders (SUDs) Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Substance Use Disorders (SUDs) Treatment market by product type and applications/end industries.
Market Segment by Companies, this report covers
Indivior
Pfizer
Alkermes
Novartis
Mylan
Cipla
Glenmark
Dr. Reddy’s Laboratories
Teva Pharmaceutical
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Opioid Addiction
Tobacco/Nicotine Addiction
Alcohol Dependence
Market Segment by Applications, can be divided into
Hospital & Clinics
Residential (non-hospital)
Table of Contents
1 Substance Use Disorders (SUDs) Treatment Market Overview
1.1 Product Overview and Scope of Substance Use Disorders (SUDs) Treatment
1.2 Classification of Substance Use Disorders (SUDs) Treatment by Types
1.2.1 Global Substance Use Disorders (SUDs) Treatment Revenue Comparison by Types (2019-2024)
1.2.2 Global Substance Use Disorders (SUDs) Treatment Revenue Market Share by Types in 2018
1.2.3 Opioid Addiction
1.2.4 Tobacco/Nicotine Addiction
1.2.5 Alcohol Dependence
1.3 Global Substance Use Disorders (SUDs) Treatment Market by Application
1.3.1 Global Substance Use Disorders (SUDs) Treatment Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital & Clinics
1.3.3 Residential (non-hospital)
1.4 Global Substance Use Disorders (SUDs) Treatment Market by Regions
1.4.1 Global Substance Use Disorders (SUDs) Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Substance Use Disorders (SUDs) Treatment Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Substance Use Disorders (SUDs) Treatment Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Substance Use Disorders (SUDs) Treatment Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Substance Use Disorders (SUDs) Treatment Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Substance Use Disorders (SUDs) Treatment Status and Prospect (2014-2024)
1.5 Global Market Size of Substance Use Disorders (SUDs) Treatment (2014-2024)
2 Manufacturers Profiles
2.1 Indivior
2.1.1 Business Overview
2.1.2 Substance Use Disorders (SUDs) Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Indivior Substance Use Disorders (SUDs) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.2 Pfizer
2.2.1 Business Overview
2.2.2 Substance Use Disorders (SUDs) Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Pfizer Substance Use Disorders (SUDs) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.3 Alkermes
2.3.1 Business Overview
2.3.2 Substance Use Disorders (SUDs) Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Alkermes Substance Use Disorders (SUDs) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.4 Novartis
2.4.1 Business Overview
2.4.2 Substance Use Disorders (SUDs) Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Novartis Substance Use Disorders (SUDs) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.5 Mylan
2.5.1 Business Overview
2.5.2 Substance Use Disorders (SUDs) Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Mylan Substance Use Disorders (SUDs) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.6 Cipla
2.6.1 Business Overview
2.6.2 Substance Use Disorders (SUDs) Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Cipla Substance Use Disorders (SUDs) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.7 Glenmark
2.7.1 Business Overview
2.7.2 Substance Use Disorders (SUDs) Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Glenmark Substance Use Disorders (SUDs) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.8 Dr. Reddy’s Laboratories
2.8.1 Business Overview
2.8.2 Substance Use Disorders (SUDs) Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Dr. Reddy’s Laboratories Substance Use Disorders (SUDs) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.9 Teva Pharmaceutical
2.9.1 Business Overview
2.9.2 Substance Use Disorders (SUDs) Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Teva Pharmaceutical Substance Use Disorders (SUDs) Treatment Revenue, Gross Margin and Market Share (2017-2018)
3 Global Substance Use Disorders (SUDs) Treatment Market Competition, by Players
3.1 Global Substance Use Disorders (SUDs) Treatment Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Substance Use Disorders (SUDs) Treatment Players Market Share
3.2.2 Top 10 Substance Use Disorders (SUDs) Treatment Players Market Share
3.3 Market Competition Trend
4 Global Substance Use Disorders (SUDs) Treatment Market Size by Regions
4.1 Global Substance Use Disorders (SUDs) Treatment Revenue and Market Share by Regions
4.2 North America Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
4.3 Europe Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
4.5 South America Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
5 North America Substance Use Disorders (SUDs) Treatment Revenue by Countries
5.1 North America Substance Use Disorders (SUDs) Treatment Revenue by Countries (2014-2019)
5.2 USA Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
5.3 Canada Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
5.4 Mexico Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
6 Europe Substance Use Disorders (SUDs) Treatment Revenue by Countries
6.1 Europe Substance Use Disorders (SUDs) Treatment Revenue by Countries (2014-2019)
6.2 Germany Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
6.3 UK Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
6.4 France Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
6.5 Russia Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
6.6 Italy Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Substance Use Disorders (SUDs) Treatment Revenue by Countries
7.1 Asia-Pacific Substance Use Disorders (SUDs) Treatment Revenue by Countries (2014-2019)
7.2 China Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
7.3 Japan Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
7.4 Korea Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
7.5 India Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
8 South America Substance Use Disorders (SUDs) Treatment Revenue by Countries
8.1 South America Substance Use Disorders (SUDs) Treatment Revenue by Countries (2014-2019)
8.2 Brazil Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
8.3 Argentina Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
8.4 Colombia Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Substance Use Disorders (SUDs) Treatment by Countries
9.1 Middle East and Africa Substance Use Disorders (SUDs) Treatment Revenue by Countries (2014-2019)
9.2 Saudi Arabia Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
9.3 UAE Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
9.4 Egypt Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
9.5 Nigeria Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
9.6 South Africa Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
10 Global Substance Use Disorders (SUDs) Treatment Market Segment by Type
10.1 Global Substance Use Disorders (SUDs) Treatment Revenue and Market Share by Type (2014-2019)
10.2 Global Substance Use Disorders (SUDs) Treatment Market Forecast by Type (2019-2024)
10.3 Opioid Addiction Revenue Growth Rate (2014-2024)
10.4 Tobacco/Nicotine Addiction Revenue Growth Rate (2014-2024)
10.5 Alcohol Dependence Revenue Growth Rate (2014-2024)
11 Global Substance Use Disorders (SUDs) Treatment Market Segment by Application
11.1 Global Substance Use Disorders (SUDs) Treatment Revenue Market Share by Application (2014-2019)
11.2 Substance Use Disorders (SUDs) Treatment Market Forecast by Application (2019-2024)
11.3 Hospital & Clinics Revenue Growth (2014-2019)
11.4 Residential (non-hospital) Revenue Growth (2014-2019)
12 Global Substance Use Disorders (SUDs) Treatment Market Size Forecast (2019-2024)
12.1 Global Substance Use Disorders (SUDs) Treatment Market Size Forecast (2019-2024)
12.2 Global Substance Use Disorders (SUDs) Treatment Market Forecast by Regions (2019-2024)
12.3 North America Substance Use Disorders (SUDs) Treatment Revenue Market Forecast (2019-2024)
12.4 Europe Substance Use Disorders (SUDs) Treatment Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Substance Use Disorders (SUDs) Treatment Revenue Market Forecast (2019-2024)
12.6 South America Substance Use Disorders (SUDs) Treatment Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Substance Use Disorders (SUDs) Treatment Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Substance Use Disorders (SUDs) Treatment Picture
Table Product Specifications of Substance Use Disorders (SUDs) Treatment
Table Global Substance Use Disorders (SUDs) Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Substance Use Disorders (SUDs) Treatment Revenue Market Share by Types in 2018
Figure Opioid Addiction Picture
Figure Tobacco/Nicotine Addiction Picture
Figure Alcohol Dependence Picture
Table Global Substance Use Disorders (SUDs) Treatment Revenue (Million USD) by Application (2014-2024)
Figure Substance Use Disorders (SUDs) Treatment Revenue Market Share by Applications in 2018
Figure Hospital & Clinics Picture
Figure Residential (non-hospital) Picture
Table Global Market Substance Use Disorders (SUDs) Treatment Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Substance Use Disorders (SUDs) Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Substance Use Disorders (SUDs) Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Substance Use Disorders (SUDs) Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Substance Use Disorders (SUDs) Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Substance Use Disorders (SUDs) Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Substance Use Disorders (SUDs) Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Table Indivior Basic Information, Manufacturing Base and Competitors
Table Indivior Substance Use Disorders (SUDs) Treatment Type and Applications
Table Indivior Substance Use Disorders (SUDs) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Substance Use Disorders (SUDs) Treatment Type and Applications
Table Pfizer Substance Use Disorders (SUDs) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Alkermes Basic Information, Manufacturing Base and Competitors
Table Alkermes Substance Use Disorders (SUDs) Treatment Type and Applications
Table Alkermes Substance Use Disorders (SUDs) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Substance Use Disorders (SUDs) Treatment Type and Applications
Table Novartis Substance Use Disorders (SUDs) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Substance Use Disorders (SUDs) Treatment Type and Applications
Table Mylan Substance Use Disorders (SUDs) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Cipla Basic Information, Manufacturing Base and Competitors
Table Cipla Substance Use Disorders (SUDs) Treatment Type and Applications
Table Cipla Substance Use Disorders (SUDs) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Glenmark Basic Information, Manufacturing Base and Competitors
Table Glenmark Substance Use Disorders (SUDs) Treatment Type and Applications
Table Glenmark Substance Use Disorders (SUDs) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table Dr. Reddy's Laboratories Substance Use Disorders (SUDs) Treatment Type and Applications
Table Dr. Reddy's Laboratories Substance Use Disorders (SUDs) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Substance Use Disorders (SUDs) Treatment Type and Applications
Table Teva Pharmaceutical Substance Use Disorders (SUDs) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Global Substance Use Disorders (SUDs) Treatment Revenue (Million USD) by Players (2014-2019)
Table Global Substance Use Disorders (SUDs) Treatment Revenue Share by Players (2014-2019)
Figure Global Substance Use Disorders (SUDs) Treatment Revenue Share by Players in 2017
Figure Global Substance Use Disorders (SUDs) Treatment Revenue Share by Players in 2018
Figure Global Top 5 Players Substance Use Disorders (SUDs) Treatment Revenue Market Share in 2018
Figure Global Top 10 Players Substance Use Disorders (SUDs) Treatment Revenue Market Share in 2018
Figure Global Substance Use Disorders (SUDs) Treatment Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Substance Use Disorders (SUDs) Treatment Revenue (Million USD) by Regions (2014-2019)
Table Global Substance Use Disorders (SUDs) Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Substance Use Disorders (SUDs) Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Substance Use Disorders (SUDs) Treatment Revenue Market Share by Regions in 2018
Figure North America Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
Figure Europe Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
Figure South America Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
Table North America Substance Use Disorders (SUDs) Treatment Revenue by Countries (2014-2019)
Table North America Substance Use Disorders (SUDs) Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Substance Use Disorders (SUDs) Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Substance Use Disorders (SUDs) Treatment Revenue Market Share by Countries in 2018
Figure USA Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
Figure Canada Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
Figure Mexico Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
Table Europe Substance Use Disorders (SUDs) Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Europe Substance Use Disorders (SUDs) Treatment Revenue Market Share by Countries (2014-2019)
Figure Europe Substance Use Disorders (SUDs) Treatment Revenue Market Share by Countries in 2018
Figure Germany Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
Figure UK Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
Figure France Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
Figure Russia Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
Figure Italy Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Substance Use Disorders (SUDs) Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Substance Use Disorders (SUDs) Treatment Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Substance Use Disorders (SUDs) Treatment Revenue Market Share by Countries in 2018
Figure China Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
Figure Japan Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
Figure Korea Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
Figure India Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
Table South America Substance Use Disorders (SUDs) Treatment Revenue by Countries (2014-2019)
Table South America Substance Use Disorders (SUDs) Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Substance Use Disorders (SUDs) Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Substance Use Disorders (SUDs) Treatment Revenue Market Share by Countries in 2018
Figure Brazil Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
Figure Argentina Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
Figure Colombia Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Substance Use Disorders (SUDs) Treatment Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Substance Use Disorders (SUDs) Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Substance Use Disorders (SUDs) Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Substance Use Disorders (SUDs) Treatment Revenue Market Share by Countries in 2018
Figure Saudi Arabia Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
Figure UAE Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
Figure Egypt Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
Figure Nigeria Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
Figure South Africa Substance Use Disorders (SUDs) Treatment Revenue and Growth Rate (2014-2019)
Table Global Substance Use Disorders (SUDs) Treatment Revenue (Million USD) by Type (2014-2019)
Table Global Substance Use Disorders (SUDs) Treatment Revenue Share by Type (2014-2019)
Figure Global Substance Use Disorders (SUDs) Treatment Revenue Share by Type (2014-2019)
Figure Global Substance Use Disorders (SUDs) Treatment Revenue Share by Type in 2019
Table Global Substance Use Disorders (SUDs) Treatment Revenue Forecast by Type (2019-2024)
Figure Global Substance Use Disorders (SUDs) Treatment Market Share Forecast by Type (2019-2024)
Figure Global Opioid Addiction Revenue Growth Rate (2014-2019)
Figure Global Tobacco/Nicotine Addiction Revenue Growth Rate (2014-2019)
Figure Global Alcohol Dependence Revenue Growth Rate (2014-2019)
Table Global Substance Use Disorders (SUDs) Treatment Revenue by Application (2014-2019)
Table Global Substance Use Disorders (SUDs) Treatment Revenue Share by Application (2014-2019)
Figure Global Substance Use Disorders (SUDs) Treatment Revenue Share by Application (2014-2019)
Figure Global Substance Use Disorders (SUDs) Treatment Revenue Share by Application in 2019
Table Global Substance Use Disorders (SUDs) Treatment Revenue Forecast by Application (2019-2024)
Figure Global Substance Use Disorders (SUDs) Treatment Market Share Forecast by Application (2019-2024)
Figure Global Hospital & Clinics Revenue Growth Rate (2014-2019)
Figure Global Residential (non-hospital) Revenue Growth Rate (2014-2019)
Figure Global Substance Use Disorders (SUDs) Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Substance Use Disorders (SUDs) Treatment Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Substance Use Disorders (SUDs) Treatment Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Substance Use Disorders (SUDs) Treatment Revenue Market Forecast (2019-2024)
Figure Europe Substance Use Disorders (SUDs) Treatment Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Substance Use Disorders (SUDs) Treatment Revenue Market Forecast (2019-2024)
Figure South America Substance Use Disorders (SUDs) Treatment Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Substance Use Disorders (SUDs) Treatment Revenue Market Forecast (2019-2024)
世界の薬物中毒治療市場予測（～2024年） Drug addiction is a complex neurobiological disease that requires integrated treatment of the mind, body, and spirit. It is considered a brain disease because drugs change the brain — they change its structure and how it works. Without treatment, these brain changes can be long-lasting. Addiction is…- 世界の薬物乱用治療市場予測（～2024年） Drug Abuse can be defined as habitually, dependence of an individual on any drugs, which turns into an addiction. Opioid, alcohol, tobacco and cigarettes are some of the common, drugs which has been misused leading to drugs addictions. In recent past, many products have been launched in market for t…
- 世界の腱炎治療市場予測（～2024年） Tendinitis is irritation or inflammation of a tendon, a thick cord that attaches muscle to bone. Tendinitis is also called tendonitis. Tendinitis mainly caused due to sudden injury or activities that put stress on the tendons. Scope of the Report: The global Tendinitis Treatment market is valued at …
- 世界の良性前立腺過形成（BPH）治療市場予測（～2024年） Benign prostatic hyperplasia (BPH), also called prostate enlargement, is a noncancerous increase in size of the prostate. Symptoms may include frequent urination, trouble starting to urinate, weak stream, inability to urinate, or loss of bladder control. Complications can include urinary tract infec…
- 世界の慢性リンパ性白血病（CLL）治療市場予測（～2024年） Treatment options for chronic lymphocytic leukemia (CLL) vary greatly, depending on the person’s age, the disease risk group, and the reason for treating (for example, which symptoms it is causing). Scope of the Report: The global Chronic Lymphocytic Leukemia (CLL) Treatment market is valued at xx m…